Peptone

Peptone is a translational biophysics company developing novel therapeutics against intrinsically disordered proteins (IDPs), a class of structurally dynamic proteins implicated in cancer, inflammation and metabolic disease.

The company combines hydrogen-deuterium exchange mass spectrometry, high-performance supercomputing and generative AI through its platform to model IDP structure and identify small-molecule druggable sites.

Peptone operates both an internal pipeline and co-development partnerships with pharmaceutical companies.